Home > Healthcare > Medical Devices > Therapeutic Devices > us otc hearing aids market
Get a free sample of U.S. OTC Hearing Aids Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of U.S. OTC Hearing Aids Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Hearing loss is public health concern that significantly impacts the quality of life and drives the disease burden. The burden of hearing loss is significant throughout a person's life and is compounded by discrimination and negative social attitudes towards those affected. Untreated hearing loss has a catastrophic financial impact on health, education, and societal productivity.
Receiver in canal (RIC) segment accounted for 33.1% market share in 2023 and will grow through 2032 due to its combination of technological advancement, discreet design, customization, and connectivity.
The U.S. OTC hearing aids industry was valued at USD 123.3 million in 2023 and is estimated to reach USD 205 million by 2032 owing to the rising prevalence of hearing loss.
GN Hearing A/S (GN Group), Sonova Holding AG, Eargo Inc., WS Audiology Denmark A/S, Bose Corporation, MD Hearing, Xiamen Melosound Technology Co., SoundWave Hearing, LLC, Lucid Hearing, Starkey, and Neuheara Limited.
Brick & mortar stores segment accounted for 59% industry share in 2023 and will grow substantially through 2032 owing to their in-person consultations with hearing professionals, the opportunity to try out and demonstrate hearing aids, immediate availability, and accessible customer support services.